Methotrexate is effective therapy for lymphomatoid papulosis and other primary cutaneous CD30-positive lymphoproliferative disorders

Eric C. Vonderheid(Johns Hopkins University), Marshall E. Kadin(Roger Williams Medical Center), Ali Sajjadian(Harvard University)
Journal of the American Academy of Dermatology
March 1, 1996
Cited by 175


Related Papers